On
In the definitive notice of the end result dated
Today, the Offeror announced a further postponement of the settlement of the Offer until
Today's announcement of the Offeror, which includes among other things further information regarding the offer conditions that remain in effect, the Offeror's intention to delist and the Offeror's action filed with the
Contact:
Tel: +61 450 909 211
Email: jimmy.baker@csl.com.au
About
About CSL
CSL (ASX: CSL; USOTC: CSLLY) is a leading global biotechnology company with a dynamic portfolio of life-saving medicines, including those that treat hemophilia and immune deficiencies, as well as vaccines to prevent influenza. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL - including our two businesses,
Forward-Looking Statements
This announcement may contain or refer to statements that constitute forward-looking statements. The words 'anticipate', 'believe', 'expect', 'estimate', 'aim', 'project', 'forecast', 'estimate', 'risk', 'likely', 'intend', 'outlook', 'should', 'could', 'would', 'may', 'will', 'continue', 'plan', 'probability', 'indicative', 'seek', 'target', 'plan' and other similar expressions are intended to identify forward-looking statements.
Any such statements, opinions and estimates in this announcement speak only as of the date hereof and are based on assumptions and contingencies subject to change without notice, as are statements about market and industry trends, projections, guidance and estimates. Forward-looking statements are provided as a general guide only. The forward-looking statements in this announcement are not indications, guarantees or predictions of future performance and involve known and unknown risks, uncertainties and other factors, many of which are beyond the control of CSL, its officers, employees, agents and advisors, and may involve significant elements of subjective judgement and assumptions as to future events which may or may not be correct, and may cause actual results to differ materially from those expressed or implied in such statements. You are strongly cautioned not to place undue reliance on forward-looking statements.
This announcement is not financial product or investment advice, a recommendation to acquire or sell securities or accounting, legal or tax advice. It does not constitute an invitation or offer to apply for securities. It has been prepared without taking into account the objectives, financial or tax situation or needs of individuals. Before making an investment decision, prospective investors should consider the appropriateness of the information having regard to their own objectives, financial and tax situation and needs and seek legal and taxation advice appropriate for their jurisdiction. CSL is not licensed to provide financial product advice in respect of an investment in securities.
(C) 2022 Electronic News Publishing, source